The Independent’s journalism is supported by our readers. When you purchase through links on our site, we may earn commission.

Scientists genetically engineer algae that can kill cancer cells while leaving the rest of the body unharmed

The new medical technology could one day help patients with types of cancer that are currently untreatable

Doug Bolton
Thursday 12 November 2015 18:32
Comments
A microscope image of cancer cells in the cervix
A microscope image of cancer cells in the cervix

A team of Australian and German scientists have managed to genetically engineer algae that can kill cancer cells while leaving normal cells unharmed.

Existing cancer treatments, including many chemotherapy remedies, kill cancer cells but also harm healthy cells, causing unpleasant side effects for patients.

So, as the researchers put in in their study, which was published this week in the high-profile Nature Communications journal, "the ability to selectively kill cancerous cell populations while leaving healthy cells unaffected is a key goal in anticancer theraputics."

Scientists have had some success in this area by using silica-based nanoparticles, but the production process is expensive, and involves the use of toxic chemicals.

Now, by using lower-cost and natural silica-based algae nanoparticles, the researchers have been able to deliver anti-cancer drugs to cancer cells without harming the body's healthy cells.

This image shows the green algae cells delivering the yellow chemotherapy drugs to the purple lymphocyte cells, which will attack the cancer cells

The scientists produced these particles by genetically engineering diatom algae, tiny single-celled algae organisms that are unique due to their cell walls, which encase the inner parts of the cell with silica.

They altered the algae so that the silica coatings of the cells were covered with a protein that binds to antibodies.

These antibodies, which make up a large part of the human immune system, then bind to the cancer cells that are attacking the body.

By 'hiding' the anti-cancer drugs within the algae, the scientists ensured that the drugs could then be delivered directly to cancer cells without coming into contact with healthy cells.

As they put it in the study, the algae cells act as 'backpacks', that bind to antibodies, which in turn bind to cancer cells, killing them but leaving normal cells without a scratch.

Unlike the costly and toxic nanoparticles that have previously been produced, algae only needs water and light to grow - making it a lower-cost and much less harmful drug delivery system.

It's still very early days for this new technology, but it holds a lot of potential - particularly for sufferers of certain brain tumours, which are currently untreatable.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in